What happens to the NPV if there’s competition? What are the worse, normal and best-case scenarios?
A financial case study of Moderna deciding whether they will attempt to develop an mRNA-based COVID-19 vaccine. Also examining the choice between in house clinical trial management versus third party outsourcing to a Contract Research Organization (CRO). Open to other suggestions on this topic Question1: What is the NPV of developing a COVID -19 vaccine? […]